Immunotherapy, Targeted Therapy Efficacy in Melanoma, and Managing Toxicities

Source: Ajmc, October 2023

During a recent Institute for Value-Based Medicine® event, speakers discussed the use of immunotherapy and targeted therapy to treat melanoma and managing the toxicities of these treatments.

Surgery had long been the only real treatment option for melanoma, but new therapies have significantly improved outcomes, explained speakers at an Institute for Value-Based Medicine® event cohosted by The American Journal of Managed Care® and Minnesota Oncology.

Melanoma is more prevalent in Minnesota than the rest of the country: the disease ranks as the third-most common malignancy in both males and females in Minnesota,1 but it is the fifth-most common malignancy in the country.2